Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Summit Therapeutics Inc. - Common Stock
(NQ:
SMMT
)
19.00
+0.33 (+1.77%)
Streaming Delayed Price
Updated: 1:00 PM EST, Dec 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
760,564
Open
18.88
Bid (Size)
18.89 (1)
Ask (Size)
19.00 (2)
Prev. Close
18.67
Today's Range
18.33 - 19.08
52wk Range
2.100 - 33.89
Shares Outstanding
97,381,774
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Where Will Summit Therapeutics Be in 5 Years?
December 20, 2024
Via
The Motley Fool
3 Stocks That Could Turn $1,000 into $5,000 by 2030
December 20, 2024
Via
The Motley Fool
Performance
YTD
+619.70%
+619.70%
1 Month
-0.99%
-0.99%
3 Month
-20.83%
-20.83%
6 Month
+137.20%
+137.20%
1 Year
+630.77%
+630.77%
More News
Read More
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
December 18, 2024
Via
The Motley Fool
2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street
December 15, 2024
Via
The Motley Fool
Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today
December 14, 2024
Via
The Motley Fool
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 13, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
How Is The Market Feeling About Summit Therapeutics?
December 13, 2024
Via
Benzinga
Why Summit Therapeutics Stock Rocketed 6% Higher on Friday
December 06, 2024
Via
The Motley Fool
Billionaire Ken Griffin Is Selling Palantir and Buying a Stock Wall Street Expects to Rocket 139% Higher
December 02, 2024
Via
The Motley Fool
Warning: This Skyrocketing Stock Has a Hidden Risk
November 30, 2024
Via
The Motley Fool
Summit Therapeutics to Present at Upcoming Investor Conferences
November 26, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
3 Monster Stocks in the Making
November 23, 2024
Via
The Motley Fool
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 21, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics
November 14, 2024
Via
Investor's Business Daily
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
November 09, 2024
Via
Benzinga
MarketBeat Week in Review – 11/4 - 11/8
November 09, 2024
Via
MarketBeat
Topics
Economy
Government
Exposures
Interest Rates
Political
2 Hot Biopharma Stocks to Buy and Hold for 5 Years
November 08, 2024
Via
The Motley Fool
Why Summit Therapeutics Stock Was a Winner Today
November 04, 2024
Via
The Motley Fool
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
November 04, 2024
Via
Benzinga
Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
November 04, 2024
Via
MarketBeat
Exposures
Product Safety
This Tencent Music Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
November 04, 2024
Via
Benzinga
3 Magnificent Stocks Under $100 to Buy in November
November 03, 2024
Via
The Motley Fool
2 Dividend Stocks to Buy for a Lifetime of Passive Income
November 02, 2024
Via
The Motley Fool
3 Stocks That Have Generated 1,000% Returns in Just 2 Years
October 31, 2024
Via
The Motley Fool
Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024
October 30, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.